SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma to acquire 15.91% stake in Krystal Biotech for $7 million

09 Aug 2017 Evaluate

Sun Pharmaceutical Industries’ one of the wholly owned subsidiaries (collectively Sun Pharma) has agreed to acquire by way of allotment to it, 203,135 Series A Preferred Stock (equivalent to 15.91% fully diluted equity stake on conversion) of Krystal Biotech Inc., United States of America, a biopharmaceutical company using gene therapy to develop treatments for patients suffering from rare debilitating disorders. The cash consideration amounting to $7 million would be paid for acquisition of shares.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.


Sun Pharma Inds. Share Price

1877.45 30.15 (1.63%)
11-May-2026 11:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1877.45
Dr. Reddys Lab 1290.00
Cipla 1332.00
Zydus Lifesciences 945.20
Lupin 2256.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×